VR Logo

Jasper Therapeutics Inc. (JSPR) download report


Healthcare | Biotechnology & Pharma Research

Jasper Therapeutics Inc. (JSPR) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies.

IPO Date: 24-Sep-2021

Co-Founder, Chair of Scientific Advisory Board & Director: Dr. Judith Anne Shizuru M.D., Ph.D.

CFO, COO & Corp. Sec.: Mr. Jeetinder Singh Mahal M.B.A.

Listing: NASDAQ: JSPR

Country: United States

Headquarters: Redwood City, CA

Website: https://jaspertherapeutics.com

Key Facts

Market cap: $76.51 Mln

Revenue (TTM): $11.05 Mln

Earnings (TTM): $-38.34 Mln

Cash: $70.40 Mln

Total Debt: $3.90 Mln

Insider's Holding: 30.91%

Liquidity: Low

52 Week range: $1.73 - 18.88

Shares outstanding: 37,876,300

Stock Performance

Time Period Jasper Therapeutics (JSPR) S&P BSE Sensex S&P Small-Cap 600
YTD-75.44-8.99-19.87
1 month-38.60-3.40-10.07
3 months-44.76-8.50-17.25
1 Year--0.89-18.01
3 Years--10.415.62
5 Years--11.435.60
10 Years--11.779.69
As on 30-Jun-2022